51 – 60 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Impact of Drug Induced Remission in Rheumatoid Arthritis
2018)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Effects of Treatment with Adalimumab on Blood Lipid Levels and Atherosclerosis in Patients with Rheumatoid Arthritis
(
- Contribution to journal › Article
-
Mark
Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients
(
- Contribution to journal › Article
- 2017
-
Mark
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
(
- Contribution to journal › Article
-
Mark
Rituximab in clinical practice : dosage, drug adherence, Ig levels, infections, and drug antibodies
(
- Contribution to journal › Article
-
Mark
Fully automated joint space width measurement and digital X-ray radiogrammetry in early RA
(
- Contribution to journal › Article
-
Mark
Blood chemokine profile in untreated early rheumatoid arthritis : CXCL10 as a disease activity marker
(
- Contribution to journal › Article
-
Mark
Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors
(
- Contribution to journal › Article
-
Mark
The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
(
- Contribution to journal › Article
-
Mark
Severe extraarticular manifestations in a community based cohort of patients with rheumatoid arthritis : Risk factors and incidence in relation to treatment with tumor necrosis factor inhibitors
(
- Contribution to journal › Article